XML 51 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Organization, Business, Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Level 3 (Details)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 3,094,065,000 $ 2,458,929,000
Senior debt and 1st lien notes    
Schedule of Equity Method Investments [Line Items]    
Fair Value 2,503,156,000 1,958,306,000
Subordinated debt and 2nd lien notes    
Schedule of Equity Method Investments [Line Items]    
Fair Value 122,748,000 148,450,000
Structured Product    
Schedule of Equity Method Investments [Line Items]    
Fair Value 80,401,000 23,947,000
Equity shares    
Schedule of Equity Method Investments [Line Items]    
Fair Value 337,684,000 297,213,000
Equity warrants    
Schedule of Equity Method Investments [Line Items]    
Fair Value 2,813,000 2,475,000
Royalty rights    
Schedule of Equity Method Investments [Line Items]    
Fair Value 14,583,000  
Level 3    
Schedule of Equity Method Investments [Line Items]    
Fair Value 2,888,065,000 2,361,224,000
Level 3 | Senior debt and 1st lien notes    
Schedule of Equity Method Investments [Line Items]    
Fair Value 2,402,177,000 1,915,633,000
Level 3 | Senior debt and 1st lien notes | Valuation, Unadjusted Prices From Independent Pricing Services And Independent Indicative Broker Quotes    
Schedule of Equity Method Investments [Line Items]    
Fair Value   28,299,000
Level 3 | Senior debt and 1st lien notes | Market Yield | Yield Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 1,975,176,000 $ 1,684,709,000
Level 3 | Senior debt and 1st lien notes | Market Yield | Yield Analysis | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.065 0.078
Level 3 | Senior debt and 1st lien notes | Market Yield | Yield Analysis | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.758 0.261
Level 3 | Senior debt and 1st lien notes | Market Yield | Yield Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.104 0.115
Level 3 | Senior debt and 1st lien notes | Adjusted EBITDA Multiple | Market Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 35,525,000 $ 17,693,000
Level 3 | Senior debt and 1st lien notes | Adjusted EBITDA Multiple | Market Approach | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.5 1.1
Level 3 | Senior debt and 1st lien notes | Adjusted EBITDA Multiple | Market Approach | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 9.0 12.5
Level 3 | Senior debt and 1st lien notes | Adjusted EBITDA Multiple | Market Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 8.2 6.5
Level 3 | Senior debt and 1st lien notes | Transaction Price | Recent Transaction    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 391,476,000 $ 184,932,000
Level 3 | Senior debt and 1st lien notes | Transaction Price | Recent Transaction | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.950 0.950
Level 3 | Senior debt and 1st lien notes | Transaction Price | Recent Transaction | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 1.000 1.000
Level 3 | Senior debt and 1st lien notes | Transaction Price | Recent Transaction | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.986 0.977
Level 3 | Subordinated debt and 2nd lien notes    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 110,909,000 $ 130,273,000
Level 3 | Subordinated debt and 2nd lien notes | Valuation, Unadjusted Prices From Independent Pricing Services And Independent Indicative Broker Quotes    
Schedule of Equity Method Investments [Line Items]    
Fair Value   1,339,000
Level 3 | Subordinated debt and 2nd lien notes | Market Yield | Yield Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 78,884,000 $ 121,811,000
Level 3 | Subordinated debt and 2nd lien notes | Market Yield | Yield Analysis | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.080 0.085
Level 3 | Subordinated debt and 2nd lien notes | Market Yield | Yield Analysis | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.186 0.210
Level 3 | Subordinated debt and 2nd lien notes | Market Yield | Yield Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.131 0.138
Level 3 | Subordinated debt and 2nd lien notes | Adjusted EBITDA Multiple | Market Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 25,667,000 $ 7,123,000
Measurement input   11
Level 3 | Subordinated debt and 2nd lien notes | Adjusted EBITDA Multiple | Market Approach | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.9  
Level 3 | Subordinated debt and 2nd lien notes | Adjusted EBITDA Multiple | Market Approach | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 22.4  
Level 3 | Subordinated debt and 2nd lien notes | Adjusted EBITDA Multiple | Market Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 14.8 11.0
Level 3 | Subordinated debt and 2nd lien notes | Transaction Price | Recent Transaction    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 702,000  
Measurement input 0.980  
Level 3 | Subordinated debt and 2nd lien notes | Transaction Price | Recent Transaction | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.980  
Level 3 | Subordinated debt and 2nd lien notes | Transaction Price | Expected Recovery    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 5,700,000  
Level 3 | Subordinated debt and 2nd lien notes | Expected Recovery | Expected Recovery    
Schedule of Equity Method Investments [Line Items]    
Fair Value   $ 5,656,000
Measurement input   5,656,100
Level 3 | Subordinated debt and 2nd lien notes | Expected Recovery | Expected Recovery | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input   5,656,100
Level 3 | Structured Product    
Schedule of Equity Method Investments [Line Items]    
Fair Value 19,899,000 $ 15,705,000
Level 3 | Structured Product | Valuation, Unadjusted Prices From Independent Pricing Services And Independent Indicative Broker Quotes    
Schedule of Equity Method Investments [Line Items]    
Fair Value 15,937,000 15,705,000
Level 3 | Structured Product | Market Yield | Yield Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value   $ 3,962,000
Measurement input   0.097
Level 3 | Structured Product | Market Yield | Yield Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input   0.097
Level 3 | Equity shares    
Schedule of Equity Method Investments [Line Items]    
Fair Value 337,684,000 $ 297,138,000
Level 3 | Equity shares | Market Yield | Yield Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 30,517,000 $ 8,788,000
Measurement input   0.146
Level 3 | Equity shares | Market Yield | Yield Analysis | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.108  
Level 3 | Equity shares | Market Yield | Yield Analysis | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.305  
Level 3 | Equity shares | Market Yield | Yield Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.141 0.146
Level 3 | Equity shares | Adjusted EBITDA Multiple | Market Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 282,073,000 $ 274,281,000
Level 3 | Equity shares | Adjusted EBITDA Multiple | Market Approach | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.5 4.8
Level 3 | Equity shares | Adjusted EBITDA Multiple | Market Approach | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 28.5 30.0
Level 3 | Equity shares | Adjusted EBITDA Multiple | Market Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 11.1 11.0
Level 3 | Equity shares | Transaction Price | Recent Transaction    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 8,843,000 $ 873,000
Level 3 | Equity shares | Transaction Price | Recent Transaction | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 1.00 1.00
Level 3 | Equity shares | Transaction Price | Recent Transaction | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 1,847.58 10.00
Level 3 | Equity shares | Transaction Price | Recent Transaction | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 1,326.31 4.07
Level 3 | Equity shares | Revenue Multiple | Market Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 1,367,000 $ 1,789,000
Level 3 | Equity shares | Revenue Multiple | Market Approach | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 5.5 6.5
Level 3 | Equity shares | Revenue Multiple | Market Approach | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 8.8 9.5
Level 3 | Equity shares | Revenue Multiple | Market Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 5.8 6.8
Level 3 | Equity shares | Discount Rate | Discounted Cash Flow Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 8,426,000 $ 6,080,000
Measurement input 0.129 0.142
Level 3 | Equity shares | Discount Rate | Discounted Cash Flow Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.129 0.142
Level 3 | Equity shares | Liabilities | Net Asset Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 6,458,000 $ 5,327,000
Measurement input 96,678,300 55,281,800
Level 3 | Equity shares | Liabilities | Net Asset Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 96,678,300 55,281,800
Level 3 | Equity warrants    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 2,813,000 $ 2,475,000
Level 3 | Equity warrants | Adjusted EBITDA Multiple | Market Approach    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 2,813,000 $ 2,475,000
Level 3 | Equity warrants | Adjusted EBITDA Multiple | Market Approach | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.5 6.3
Level 3 | Equity warrants | Adjusted EBITDA Multiple | Market Approach | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 11.8 12.5
Level 3 | Equity warrants | Adjusted EBITDA Multiple | Market Approach | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 8.0 7.3
Level 3 | Royalty rights    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 14,583,000  
Level 3 | Royalty rights | Market Yield | Yield Analysis    
Schedule of Equity Method Investments [Line Items]    
Fair Value $ 14,583,000  
Level 3 | Royalty rights | Market Yield | Yield Analysis | Minimum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.186  
Level 3 | Royalty rights | Market Yield | Yield Analysis | Maximum    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.264  
Level 3 | Royalty rights | Market Yield | Yield Analysis | Weighted Average    
Schedule of Equity Method Investments [Line Items]    
Measurement input 0.210